Back to Blog
Bardy diagnostics6/22/2023 The telehealth monitoring market has grown tremendously in recent years, fueled by increasing awareness of the benefits of remote monitoring and home healthcare. The home application program eliminates the need for in-person patient and healthcare provider contact, reduces the potential for exposure to COVID-19, streamlines care, and allows healthcare personnel who are already resource-constrained to focus on other areas of critical need.” Ken Nelson, the CCO of Bardy Diagnostics, stated that “To help address the evolving needs of physicians and patients in this public health emergency, facilitate the rapid transition to telehealth for clinics around the country and to ensure uninterrupted access to our CAM patch, our team has worked around the clock to increase our manufacturing capacity and expand our internal business operations to enable patients to receive and apply our disposable, single-use CAM patch at home. Monitoring more individuals remotely will also help to lessen the spread of COVID-19. HCQ use sometimes carries dangerous and life-threatening side-effects such as drug-induced sudden cardiac death, according to the CDC.īecause the CAM can be worn on patients and tracked remotely, this means patients can be monitored while in the comfort of their own home, and hospital settings benefit from increased space. residents were recently experimentally given hydroxychloroquine (HCQ) to treat COVID-19 symptoms. These devices have also seen an increase in prescription as some U.S. Longer monitoring periods provide healthcare providers with the opportunity to potentially detect infrequent arrhythmias that may go unnoticed during a shorter period of time.ĬAM patches are now increasingly being prescribed for home use, as hospital space has become limited. The patches allow for a longer period of monitoring than previous products, that were used for 2 or 7-day periods. hospital settings, but they have now been granted a CE mark for these products. Image courtesy of Bardy Diagnostics.īardy Diagnostics‘ 14-day Carnation Ambulatory Monitor (CAM) patches have previously been used in U.S. and Europe and fits within existing reimbursement codes in each region.The Carnation Ambulatory Monitor patch can monitor patients for up to 14 days. The CAM™ data file can be quickly downloaded for analysis at a hospital or clinic or at a third-party reading site, whichever the customer prefers. The earlier intervention and proper treatment of arrhythmias has the potential to drastically reduce their long-term complications and related costs. Gust Bardy, CAM™ is a non-invasive cardiac monitor worn by patients to record heart rhythms for extended periods of time.ĭue to its novel engineering and design, unique data capture and presentation capabilities and improved patient compliance, CAM™ improves the prospects for clinically actionable arrhythmia diagnoses and timely interventions. Incorporating the extensive research, clinical expertise and intellectual property of Dr. (“BardyDx”) has developed and is commercializing the Carnation Ambulatory Monitor (“CAM™”), the world’s smallest and lightest P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device.
0 Comments
Read More
Leave a Reply. |